Footnotes

• Handling editor Jackie A Cassell

• Contributors ST conceived the idea of this editorial. RJ and ST drafted the first version of this manuscript, with input from VD and KZN. VD provided data from PHE. All authors approved the final version of this manuscript prior to submission.

• Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

• Competing interests RJ sits on the Advisory Board of the Terrence Higgins Trust and is a Trustee of Saving Lives. KN has previously received speaker honoraria from Gilead Sciences and Merck, Sharpe and Dohme, and acted in a consultancy capacity for Viiv Heathcare. KN is a trustee of the Clare Project (registered charity 1165746) which provides peer support services for trans and non-binary people in Brighton, UK. ST has previously received a travel bursary funded by Janssen-Cilag through the British HIV Association, speaker honoraria and funding for preparation of educational materials from Gilead Sciences, and is a member of the steering group of SWIFT, a networking group for people involved in research in HIV and women, funded by Bristol Myers Squibb.

• Provenance and peer review Commissioned; internally peer reviewed.